I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Eberlein, Cath
24
results:
Search for persons
X
Format
Online (24)
Mediatypes
Articles (Online) (12)
OpenAccess-fulltext (12)
Sorted by: Relevance
Sorted by: Year
?
1
Capivasertib combines with docetaxel to enhance anti-tumour..:
Eberlein, Cath
;
Williamson, Stuart C.
;
Hopcroft, Lorna
...
British Journal of Cancer. 130 (2024) 8 - p. 1377-1387 , 2024
Link:
https://doi.org/10.1038/..
?
2
Pharmacokinetics of the Akt Serine/Threonine Protein Kinase..:
Miller, Claire
;
Sommavilla, Roberto
;
Barry, Simon T.
...
Clinical Pharmacology in Drug Development. 12 (2023) 9 - p. 856-862 , 2023
Link:
https://doi.org/10.1002/..
?
3
Author Correction: Combining the AKT inhibitor capivasertib..:
Hopcroft, Lorna
;
Wigmore, Eleanor M.
;
Williamson, Stuart C.
...
npj Breast Cancer. 9 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
4
Author Correction: Combining the AKT inhibitor capivasertib..:
Hopcroft, Lorna
;
Wigmore, Eleanor M.
;
Williamson, Stuart C.
...
npj Breast Cancer. 9 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
5
Combining the AKT inhibitor capivasertib and SERD fulvestra..:
Hopcroft, Lorna
;
Wigmore, Eleanor M.
;
Williamson, Stuart C.
...
npj Breast Cancer. 9 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
6
AKT-mTORC1 reactivation is the dominant resistance driver f..:
Dunn, Shanade
;
Eberlein, Cath
;
Yu, Jason
...
Oncogene. 41 (2022) 46 - p. 5046-5060 , 2022
Link:
https://doi.org/10.1038/..
?
7
Mixed micelles of lipoic acid-chitosan-poly(ethylene glycol..:
Elsaid, Zeeneh
;
Taylor, Kevin M.G.
;
Puri, Sanyogitta
...
European Journal of Pharmaceutical Sciences. 101 (2017) - p. 228-242 , 2017
Link:
https://doi.org/10.1016/..
?
8
Utilization of Structure-Based Design to Identify Novel, Ir..:
Hennessy, Edward J.
;
Chuaqui, Claudio
;
Ashton, Susan
...
ACS Medicinal Chemistry Letters. 7 (2016) 5 - p. 514-519 , 2016
Link:
https://doi.org/10.1021/..
?
9
Inhibition of oxidative phosphorylation suppresses the deve..:
Martin, Matthew J.
;
Eberlein, Cath
;
Taylor, Molly
...
Oncotarget. 7 (2016) 52 - p. 86313-86325 , 2016
Link:
https://doi.org/10.18632..
?
10
In vitro pharmacological profiling of R406 identifies molec..:
Rolf, Michael G.
;
Curwen, Jon O.
;
Veldman‐Jones, Margaret
...
Pharmacology Research & Perspectives. 3 (2015) 5 - p. , 2015
Link:
https://doi.org/10.1002/..
?
11
Structure- and Reactivity-Based Development of Covalent Inh..:
Ward, Richard A.
;
Anderton, Mark J.
;
Ashton, Susan
...
Journal of Medicinal Chemistry. 56 (2013) 17 - p. 7025-7048 , 2013
Link:
https://doi.org/10.1021/..
?
12
Placental growth factor neutralising antibodies give limite..:
Brave, Sandra R.
;
Eberlein, Cath
;
Shibuya, Masabumi
..
Angiogenesis. 13 (2010) 4 - p. 337-347 , 2010
Link:
https://doi.org/10.1007/..
?
13
Author Correction: Combining the AKT inhibitor capivasertib..:
Hopcroft, Lorna
;
Wigmore, Eleanor M
;
Williamson, Stuart C
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439172/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
14
Combining the AKT inhibitor capivasertib and SERD fulvestra..:
Hopcroft, Lorna
;
Wigmore, Eleanor M
;
Williamson, Stuart C
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404292/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
15
Author Correction: Combining the AKT inhibitor capivasertib..:
Hopcroft, Lorna
;
Wigmore, Eleanor M
;
Williamson, Stuart C
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509253/. , 2023
Link:
http://www.ncbi.nlm.nih...
1-15
